Romano Kelly A — SEC Form 4 filings
SEC reporting owner CIK 1722055. 14 Form 4 filings on record with FilingPulse; latest filed 2026-06-24.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-01-30 to 2026-06-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 42,400 shares, $100,051 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: purchase of 27,400 shares @ $2.42 ($66,179) in LeonaBio, Inc., filed 2024-06-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LeonaBio, Inc. (LONA) | Director | 5 | 2 legs · 42,400 sh · $100,051 | — | 4 |
| Dorman Products, Inc. (DORM) | Director | 6 | — | — | 6 |
| UGI CORP /PA/ (UGI) | Director | 3 | — | — | 4 |
Form 4 filings — Romano Kelly A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-24 | 4 | LeonaBio, Inc. (LONA) | Grant/award (A): 28,000 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Dorman Products, Inc. (DORM) | Grant/award (A): 1,344 @ $122.71 | EDGAR |
| 2026-05-19 | 4 | Dorman Products, Inc. (DORM) | Tax withholding (F): 33 @ $116.16 | EDGAR |
| 2026-04-13 | 4 | LeonaBio, Inc. (LONA) | Grant/award (A): 28,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | UGI CORP /PA/ (UGI) | Grant/award (A): 4,364 @ $0 | EDGAR |
| 2025-06-04 | 4 | Dorman Products, Inc. (DORM) | Grant/award (A): 1,070 @ $0 | EDGAR |
| 2025-06-03 | 4 | Athira Pharma, Inc. (ATHA) | Grant/award (A): 20,900 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | Dorman Products, Inc. (DORM) | Tax withholding (F): 46 @ $132.03 | EDGAR |
| 2025-02-04 | 4 | UGI CORP /PA/ (UGI) | Grant/award (A): 5,695 @ $0 | EDGAR |
| 2024-06-25 | 4 | Athira Pharma, Inc. (ATHA) | Purchase (P): 15,000 @ $2.26 · Purchase (P): 27,400 @ $2.42 | EDGAR |
| 2024-06-04 | 4 | Dorman Products, Inc. (DORM) | Grant/award (A): 1,471 @ $0 | EDGAR |
| 2024-05-24 | 4 | Athira Pharma, Inc. (ATHA) | Grant/award (A): 20,900 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | Dorman Products, Inc. (DORM) | Tax withholding (F): 47 @ $91.33 | EDGAR |
| 2024-01-30 | 4 | UGI CORP /PA/ (UGI) | Grant/award (A): 4,470 @ $0 · Grant/award (A): 12,890 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1722055 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →